Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05744856
Other study ID # VALID II
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 16, 2023
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source Thai Binh University of Medicine and Pharmacy
Contact Thanh Duc Nguyen, MD
Phone +84 091 235 7575
Email bsthanh@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gestational Diabetes Mellitus (GDM) is significant public health problem in Vietnam, which is potentially treatable if managed properly by the pregnant women once diagnosed. However, systematic screening for GDM is rarely undertaken in Vietnam, and little is known about how health providers, pregnant women, and their families in today's Vietnam handle the condition. Vietnamese women often depend on their extended family for daily life management and access to social and financial resources, hence, an intervention that focuses on informal support and GDM self-care may increase adherence the standard guidelines among pregnant women with GDM in Vietnam and increase neonatal and maternal health outcomes.


Description:

Background: Across the globe, diabetes mellitus is attaining epidemic proportions, with low- and middle-income countries confronting particularly high burdens. VALID II focuses on gestational diabetes mellitus (GDM), a transitory form of diabetes that presents during pregnancy. Objectives: To: i) Determine prevalence and risk factors for GDM among pregnant women in Vietnam's Thai Binh province, ii) Measure the associations between GDM and pregnancy complications and outcomes, iii) Understand how pregnant women with GDM and their informal support persons perceive and handle the condition, iv) Co-create, implement, and assess the feasibility of a intervention aiming to enhance the self-care capacities of pregnant women with GDM. Study setting: Thai Binh, Vietnam Study design: Intervention study Study population: 2,000 pregnant women attending antenatal care. Methodology: The study will be performed as a pilot parallel 2-arm non-randomized intervention study with a delayed-start for the intervention group. 1000 women will be invited into the study at their first antenatal care visit (gestational week 12) and complete a questionnaire (inclusion questionnaire). All women will be offered a 2-hour oral glucose tolerance test (OGTT) in gestational week 24-28 and complete second questionnaire (OGTT questionnaire) exploring living conditions, lifestyle, risk factors, selfcare, perceived social support, perceived wellbeing, and sign of depression. An estimated 200 women (~20%) will screen positive for GDM by the OGTT according to the World Health Organization (WHO) 2013 diagnostic criteria and receive standard GDM care. These 200 women will serve as the study's control group (study phase I). Among the 200 women who screen positive in phase I, ethnographic interviews will be formed in a subgroup of 20 women. The information from the 20 ethnographic interviews and the 200 questionnaire interviews will help inform a co-created "self-care and informal support" intervention. Subsequently, another 1000 women will be invited into the study at their first antenatal care visit and be offered a 2-hour oral glucose tolerance test (OGTT) in gestational week 24-28 (study phase II). An estimated 200 women (~20%) will screen positive for GDM, and these women will receive the co-created intervention and serve as the study's intervention group. Additionally, all women (both intervention and control group) will be interviewed in gestational week 32-36 and 8-12 weeks postpartum. Further, information about HbA1c, maternal BMI, gestational weight gain, mode of delivery, neonatal weight as well as obstetric and neonatal complications will be obtained from measurements and the delivery records. The primary endpoint will be large for gestational age. Secondary neonatal endpoints will be macrosomia, preterm birth, stillborn/neonatal death and neonatal hypoglycemia. Secondary maternal outcomes will be HbA1c, hypertensive disorders, gestational weight gain, caesarean section, women's GDM self-care, perceived social support, perceived wellbeing, signs of depression, breastfeeding rates, quality of life, and empowerment. The outcome of this intervention pilot study will determine whether the intervention can be feasibly delivered within the context of a full-scale randomized controlled trial (RCT). Thus, the pilot study will not be powered to detect statistical differences in key clinical outcomes, but the sample sizes have been chosen to highlight problems and confirm the potential to detect differences. Women may be included in the study all the way up to gestational age 28 depending on when they attend their first antenatal care appointment and receive the OGTT. Further, the point in time of the different questionnaire interviews may vary according to the needs of the pregnant women and when she delivers.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date December 31, 2025
Est. primary completion date October 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Pregnancy < 28 weeks - Singleton and multiple pregnancies - Residing in Thai Binh province - Speaks and reads Vietnamese - Agree to participate voluntarily (informed consent) Exclusion Criteria: - Pre-gestational diabetes (type I or type II) - Severe chronic disease Women with GDM in a prior pregnancy are eligible for inclusion into the study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Self-care with informal support
The detailed content of the "self-care with informal support intervention" will be developed at participatory co-creation workshops involving pregnant women with GDM, their informal support persons, and health care staff. It is expected that intervention will include educational pamphlets regarding GDM and digital GDM education through videos and text messages. Further, digital coaching will be conducted and networking among intervention participants via the Vietnamese messaging app Zalo. In addition, each woman will be invited to include one informal support person in the intervention activities. GDM education will concern coaching on diet and exercise during pregnancy and after delivery and coaching on breastfeeding and infant/child nutrition.

Locations

Country Name City State
Vietnam Thai Binh Maternity Hospital Thai Binh
Vietnam Kim Ngan Clinic Thái Bình

Sponsors (3)

Lead Sponsor Collaborator
Thai Binh University of Medicine and Pharmacy University of Copenhagen, University of Southern Denmark

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Other Diet Change in diet measured through ad hoc developed questions Study month 3 and 6/Gestational age 24 and 36
Other Physical activity Change in physical activity measured through ad hoc developed questions Study month 3 and 6/Gestational age 24 and 36
Other Episiotomy Number of participants where episiotomy is performed during delivery Delivery (study month 7/Gestational age 40)
Other PPROM Number of participants with Premature Primary Rupture of Membranes Delivery (study month 7/Gestational age 40)
Other Prevalence of GDM Number of participants with GDM diagnosed according to WHO criteria Study month 3/Gestational age 24
Other Risk factors of GDM Number of pre-gestational and gestational risk factors for GDM prevalent among participants diagnosed with GDM (risk factor are defined as according to those known in the literature, e.g. age, BMI, family disposition, gestational weigh gain) Study month 3/Gestational age 24
Other Perception of GDM Ethnographic study conducted among approximately 40 pregnant women with GDM and their informal support persons (20 from intervention group and 20 from control group) Study month 3 to 7/Gestational age 24 to 40 (delivery)
Other GDM self-care practices Ethnographic study conducted among approximately 40 pregnant women with GDM and their informal support persons (20 from intervention group and 20 from control group) Study month 3 to 7/Gestational age 24 to 40 (delivery)
Other Perception of "self-care/informal support" intervention Ethnographic study conducted among approximately 20 pregnant women with GDM and their informal support persons (intervention group) Study month 3 to 10/Gestational age 24 to 12 weeks post-partum
Other Family health The short form version of the Family Health Scale [10 items on a 5-point scale ranging from 1-5]. A total score of 0-5 indicates poor family health, 6-8 indicates moderate family health, and 9-10 indicates excellent family health Study month 6/Gestational age 36
Other Costs Direct economic costs (in Vietnamese Dong/VND and USD) and indirect costs (human ressources measured in hours) spent on developing the intervention Throughout whole study (study month 0-10)
Primary Large for gestational age (LGA) Number of newborns with birth weight above the 90th percentile according to gender and gestational age (INTERGROWTH) Delivery (study month 7 after enrolment/Gestational age 40)
Primary The feasibility of the self-care intervention [recruitment] Number of women eligible for the study who accepts to be included in the intervention arm. Recruitment (study month 0)
Primary The feasibility of the self-care intervention [retention] Number of included women in the intervention group who completes the study (delivery data and post-partum interview). Recruitment to post-partum evaluation (study month 0-10)
Primary The acceptability of the self-care intervention Acceptability will be measured in a combined quantitative and qualitative study. It will be measured quantitatively via 5-point likert scales among the intervention group [Range: 1-5; Minimum score: 1; Maximum score: 5; Higher score indicates high acceptability]. It will be assessed qualitatively among a sub-group of the intervention group through a ethnographic study. Study month 3 to 10 /Gestational age 24 to 12 weeks post-partum
Secondary Mode of delivery Number of participants with spontaneous vaginal delivery, assisted vaginal delivery, planned c-section or emergency c-section Delivery (study month 7/Gestational age 40)
Secondary Pre-term birth below gestational age 37+0 Number of participants with spontaneous preterm birth or medical induced preterm birth Delivery (study month 7/Gestational age 40)
Secondary Gestational age The gestational age of newborns at delivery Delivery (study month 7/Gestational age 40)
Secondary Birth weight Birth weight of newborns measured in grams Delivery (study month 7/Gestational age 40)
Secondary Macrosomia Number of newborns with birth weight above 4000g Delivery (study month 7/Gestational age 40)
Secondary Macrosomia (Vietnam) Number of newborns with birth weight above 3500g Delivery (study month 7/Gestational age 40)
Secondary Live-born Newborns that are live-born (Yes/no) Delivery (study month 7/Gestational age 40)
Secondary Small for gestational age (SGA) Number of newborns below the 10th percentile for birth weight according to gestational age Delivery (study month 7/Gestational age 40)
Secondary Apgar score The Apgar score of newborns measured 1 and 5 minutes after delivery (score: 0-10) Delivery (study month 7/Gestational age 40)
Secondary Neonatal hypoglycemia Measurement of blood glucose (mmol/l) in newborns Delivery (study month 7/Gestational age 40)
Secondary Maternal gestational weight gain Change in delta weight (kilogram) among participants between gestational age 36 minus first measured/pre-gestational weight Study month 0 and 6/Gestational age 12 and 36
Secondary HbA1c Change in delta score among participants between gestational age 24 and 40 (delivery) Study month 3 and 7/Gestational age 24 and 40 (delivery)
Secondary Breast feeding practices Participants' breast feeding practices measured through ad hoc developed questions Study month 10 (12 weeks post-partum)
Secondary Post-partum depression Change in delta score among participants measured through the Edinburgh postpartum depression scale (EPDS) [10 items on 4-point scale ranging from 0-3] Study month 3 and 10/Gestational age 24 and 12 weeks postpartum
Secondary Perceived social support Change in delta score among participants measured through the Multidimensional Scale of Perceived Social Support scale (MSPSS) [11 item 7-point scale ranging from 1-7] Study month 3,6 and 10/Gestational age 24, 36 and 12 weeks postpartum
Secondary Well-being Change in delta scores measured through WHO 5 Wellbeing index [5 items on 6-point scale ranging from 0-5] Study month 0, 3, 6 and 10/Gestational age 12, 24, 36 and 12 weeks postpartum
Secondary Self-care Agency Difference in score between intervention and comparator group measured through the Self-care Agency Scale-Revised (ASAS-R) [15 items on 5-point scale ranging from 1-5] Study month 3 and 6/Gestational age 24 and 36
Secondary Self-care of GDM Difference in score between intervention and comparator group measured through the Summary of Diabetes Self- Care Activities (SDSCA) [10 items on 8-point scale ranging 0-7] Study month 6/Gestational age 36
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02838147 - Effect of a Continuous Glucose Monitoring on Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus Phase 3
Enrolling by invitation NCT01762826 - Myo-inositol, D-chiro-inositol, and D-chiro/Myo-inositol in Gestational Diabetes N/A
Recruiting NCT04192422 - DiGESTnewborn Study
Not yet recruiting NCT02916667 - Chrono Nutrition (CN) Intervention Program in Gestational Diabetes Mellitus N/A
Terminated NCT04146909 - The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women N/A
Completed NCT05355038 - Effect of Lifestyle Modification on Pregnancy Outcome for GDM N/A
Completed NCT03748576 - A Prospective Randomized Controlled Trial of Mobile Medical Used for Management of Pregnant Women N/A
Not yet recruiting NCT06436794 - "Mantou" Screening for GDM Before 20 Weeks of Gestation
Recruiting NCT04930276 - Diet-glucose-gut Microbiome Net in Women With GDM N/A
Active, not recruiting NCT02495987 - White Adipose Tissue in Pregnancy Study
Active, not recruiting NCT04424238 - the Effect of Mobile Medical Used for the Standardized Management of Gestational Diabetes N/A
Active, not recruiting NCT04794283 - Antenatal Hand Milking for Pregnant Women With Diabetes'
Recruiting NCT05881616 - Study on Serum Metabolomics of GDM
Recruiting NCT06127823 - Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL N/A
Recruiting NCT05204706 - The MalaYsian GestatiOnal Diabetes and Prevention of DiabetES Study N/A
Enrolling by invitation NCT05212519 - Correlation of Vitamin D Levels in Early Pregnancy With Gestational Diabetes and Pregnancy Outcomes
Recruiting NCT03589092 - Genetic Causes of Gestational Diabetes in the Emirati Population
Completed NCT03426228 - In Vitro Fertilization Impact on Metabolic Parameters
Recruiting NCT06125704 - Time to Move in Pregnancy Hyperglycemia N/A
Recruiting NCT03981328 - The Effectiveness of Rt-CGM to Improve Glycemic Control and Pregnancy Outcome in Patients With GDM N/A